,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['breast', 'enhertu', 'astrazeneca', 'daiichi']
asco: astrazeneca, daiichi s enhertu could transform breast cancer treatment with landmark her2-low show 
Access to First Databank's drug pricing database with more than 90 attributes & data points for virtually every FDA approved drug. #DrugPricing 

RT?Endorsement